Details for Vaqta vaccine and its components.
Registered for use in people aged ≥12 months.
Monovalent hepatitis A vaccine
Each 1.0 mL monodose vial or pre-filled syringe contains:
- approximately 50 units of hepatitis A virus protein
- 0.45 mg aluminium as aluminium hydroxide
- 70 µg borax
Each 0.5 mL monodose vial or pre-filled syringe contains:
- approximately 25 units of hepatitis A virus protein
- 0.225 mg aluminium as aluminium hydroxide
- 35 µg borax
Both formulations contain traces of:
- bovine serum albumin
For detailed advice on vaccine dosage, administration, contraindications and precautions, please visit the relevant disease chapter.
Printed content may be out of date. For up to date information, always refer to the digital version: https://immunisationhandbook.health.gov.au/vaccines/vaqta.